According to Boyer’s model, a single vial of antivenom that would cost more than $14,000 in the United States would cost $100 to $200 in Mexico. Same medicine. Same manufacturer. But a totally different pharmaceutical market.

https://www.washingtonpost.com/news/wonkblog/wp/2015/09/09/the-crazy-reason-it-costs-14000-to-treat-a-snakebite-with-14-medicine/

4 thoughts on “According to Boyer’s model, a single vial of antivenom that would cost more than $14,000 in the United States would…

  1. The hospital I work at doesn’t even stock antivenin. It has an extremely short shelflife, so we can’t afford (this being a small, county-operated hospital) to shell out a couple thousand for a dose of something that we will probably have to throw away (this is made worse by having three different venomous snakes in the area). So whenever we do get a patient with a snakebite (which surprisingly doesn’t happen very often) we have to transfer them to another hospital, which makes it even more expensive for the patient.

    I’m not surprised that so much of the final cost comes down to insurance shenanigans. So many things do. (I get asked by patents very often, “Do y’all take this insurance?” but that’s not even the issue. The issue is whether the insurance company will deign to pay. Hospitals have to bend over backwards to make sure that insurance companies will reliably pay for their subscribers’ medical bills.)